News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,440 Results
Type
Article (86201)
Company Profile (655)
Press Release (752584)
Section
Business (232325)
Career Advice (4125)
Deals (39706)
Drug Delivery (127)
Drug Development (90862)
Employer Resources (198)
FDA (18025)
Job Trends (17315)
News (395815)
Policy (39689)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (8)
2025 Lone Star Bio Digital (10)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2986)
Academic (1)
Accelerated approval (5)
Adcomms (29)
Allergies (81)
Alliances (56679)
ALS (87)
Alzheimer's disease (1455)
Antibody-drug conjugate (ADC) (133)
Approvals (18017)
Artificial intelligence (224)
Autoimmune disease (21)
Automation (10)
Bankruptcy (403)
Best Places to Work (12558)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (448)
Bladder cancer (59)
Brain cancer (26)
Breast cancer (237)
Cancer (1970)
Cardiovascular disease (151)
Career advice (3529)
Career pathing (33)
CAR-T (154)
Cell therapy (434)
Cervical cancer (17)
Clinical research (72884)
Collaboration (770)
Compensation (432)
Complete response letters (30)
COVID-19 (2840)
CRISPR (42)
C-suite (206)
Cystic fibrosis (98)
Data (1836)
Decentralized trials (2)
Denatured (43)
Depression (40)
Diabetes (216)
Diagnostics (6754)
Digital health (10)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (117)
Drug pricing (120)
Drug shortages (32)
Duchenne muscular dystrophy (88)
Earnings (95486)
Editorial (38)
Employer branding (25)
Employer resources (167)
Events (128379)
Executive appointments (604)
FDA (19013)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (631)
Gene editing (99)
Generative AI (21)
Gene therapy (302)
GLP-1 (791)
Government (5108)
Grass and pollen (4)
Guidances (36)
Healthcare (20766)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (25)
Infectious disease (2967)
Inflammatory bowel disease (146)
Inflation Reduction Act (11)
Influenza (44)
Intellectual property (87)
Interviews (812)
IPO (17719)
IRA (51)
Job creations (5184)
Job search strategy (2861)
Kidney cancer (10)
Labor market (37)
Layoffs (535)
Leadership (20)
Legal (10082)
Liver cancer (70)
Lung cancer (288)
Lymphoma (130)
Machine learning (3)
Management (65)
Manufacturing (286)
MASH (66)
Medical device (14308)
Medtech (14313)
Mergers & acquisitions (22308)
Metabolic disorders (650)
Multiple sclerosis (75)
NASH (23)
Neurodegenerative disease (97)
Neuropsychiatric disorders (30)
Neuroscience (1960)
NextGen: Class of 2025 (7667)
Non-profit (5056)
Northern California (2251)
Now hiring (38)
Obesity (368)
Opinion (269)
Ovarian cancer (70)
Pain (82)
Pancreatic cancer (66)
Parkinson's disease (137)
Partnered (19)
Patents (201)
Patient recruitment (91)
Peanut (48)
People (64846)
Pharmaceutical (137)
Pharmacy benefit managers (21)
Phase I (22501)
Phase II (31669)
Phase III (23856)
Pipeline (1030)
Podcasts (122)
Policy (134)
Postmarket research (3547)
Preclinical (10099)
Press Release (72)
Prostate cancer (92)
Psychedelics (35)
Radiopharmaceuticals (258)
Rare diseases (375)
Real estate (7381)
Recruiting (75)
Regulatory (26497)
Reports (57)
Research institute (2646)
Resumes & cover letters (649)
Rett syndrome (1)
RNA editing (4)
RSV (38)
Schizophrenia (71)
Series A (119)
Series B (72)
Service/supplier (26)
Sickle cell disease (50)
Southern California (1979)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (33)
Startups (4281)
State (2)
Stomach cancer (14)
Supply chain (61)
Tariffs (14)
The Weekly (77)
United States (20037)
Vaccines (733)
Venture capitalists (38)
Webinars (13)
Weight loss (277)
Women's health (36)
Worklife (19)
Date
Today (92)
Last 7 days (618)
Last 30 days (2437)
Last 365 days (32408)
2025 (7665)
2024 (35453)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1266)
Alabama (52)
Alaska (6)
Arizona (239)
Arkansas (11)
Asia (49847)
Australia (8798)
California (5202)
Canada (1716)
China (475)
Colorado (185)
Connecticut (220)
Delaware (118)
Europe (114091)
Florida (706)
Georgia (152)
Hawaii (1)
Idaho (64)
Illinois (508)
India (25)
Indiana (279)
Iowa (10)
Japan (137)
Kansas (108)
Kentucky (21)
Louisiana (8)
Maine (58)
Maryland (847)
Massachusetts (4095)
Michigan (178)
Minnesota (320)
Mississippi (2)
Missouri (56)
Montana (24)
Nebraska (26)
Nevada (52)
New Hampshire (50)
New Jersey (1555)
New Mexico (30)
New York (1478)
North Carolina (1018)
North Dakota (7)
Northern California (2251)
Ohio (166)
Oklahoma (13)
Oregon (44)
Pennsylvania (1151)
Puerto Rico (10)
Rhode Island (26)
South America (1649)
South Carolina (6)
South Dakota (1)
Southern California (1979)
Tennessee (52)
Texas (714)
Utah (116)
Virginia (127)
Washington D.C. (56)
Washington State (513)
West Virginia (1)
Wisconsin (41)
839,440 Results for "tetra bio pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder
March 25, 2025
·
4 min read
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025
March 18, 2025
·
2 min read
Press Releases
Pharma-Bio Serv Announces Special Dividend
January 30, 2025
·
2 min read
Podcast
Trump’s Pharma Tariffs, Another GLP-1 Compounding Lawsuit, Bluebird’s Bailout, More
As FDA seeks to rehire some fired employees, Donald Trump threatens to enact tariffs on pharma companies unless they reshore manufacturing; another lawsuit hits the complex GLP-1 compounding space as Eli Lilly offers expanded Zepbound options; and struggling gene therapy biotech bluebird bio goes private in an attempt to stay solvent.
February 26, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Pharma-Bio Serv Announces Full Year Results
January 30, 2025
·
3 min read
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Tetra Bio-Pharma Announces Listing to OTCPink Market
Tetra Bio-Pharma Inc. announced that its common shares began trading on the OTC Markets Group’s OTCPink Market in the United States under the symbol “TBPMF” effective at the opening of trading on Friday, February 10, 2023 and will continue to trade on the Toronto Stock Exchange under the ticker symbol “TBP”.
February 10, 2023
·
4 min read
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003
Tetra Bio-Pharma Inc. today announced the filing of three patent applications for its novel therapeutic, ARDS-003.
November 29, 2022
·
5 min read
Pharm Country
Acasti Pharma to Attend BIO International Convention 2024
Acasti Pharma Inc. announced that the Company will be participating in the BIO International Convention taking place at the San Diego Convention Center from June 3-6, 2024.
May 28, 2024
·
6 min read
1 of 83,944
Next
